Chris Anderton

Coming Soon!

Will Fondrie

Coming Soon!

Kylie Be

Coming Soon!

Michael Lazear

Coming Soon!

Laurie Parker

Coming Soon!

Brian Searle

Coming Soon!

Lindsay Pino

Coming Soon!

Mary-Claire King

Coming Soon!

Fan Liu

Fan graduated from Fudan University in Shanghai with a B.Sc. in Biology. Afterwards she joined the lab of Prof. Dr. Mike Goshe at North Carolina State University and obtained her PhD in Biochemistry in 2013. Fan did her postdoc in the lab of Prof. Dr. Albert Heck (Utrecht, The Netherlands). In 2017 Fan joined the Leibniz-Forschungsinstitut for Molecular Pharmacology (FMP) in Berlin as a group leader for Structural Interactomics and head of the proteomics research platform. In addition to her position at the FMP, Fan is jointly appointed as Professor for Structural Interactomics at Charité - Universitätsmedizin Berlin.

Lan Huang

Coming Soon!

Edward Lau

I am an Assistant Professor at the Department of Medicine at the University of Colorado School of Medicine. Prior to starting my lab in Colorado, I completed my PhD at the University of California Los Angeles followed by a postdoctoral fellowship at Stanford University. Research in my group aims to understand how the spatial and temporal dynamics of the proteome are regulated in development, aging, and disease. In prior work, we have developed the protocol and software to apply heavy water and stable isotope labeled amino acids to measure the half-life of thousands of proteins across multiple mouse tissues (Hammond […] Beynon, Lau; MCP 2022); applied machine learning methods to unravel genewise differences in mRNA-protein correlation and its regulation (Srivastava et al. PLoS Comput Bill 2022); and developed a new method to simultaneously trace the subcellular localization and turnover rates of proteins in cell culture, which is being utilized toward identifying new elements of proteostatic stress response and drug induced cardiotoxicity (Currie et al. bioRxiv 2023). 

Rovshan Sadygov

Rovshan G. Sadygov, Ph.D., Associate Professor, Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX

Bobbie-Jo Webb-Robertson

Bobbie-Jo Webb-Robertson is the Director of the Biological Sciences Division with the Earth and Biological Sciences Directorate at Pacific Northwest National Laboratory. In addition, she holds joint appointments in the Department of Biomedical Engineering at Oregon Health & Science University, the Department of Pathology, Immunology and Laboratory Medicine at the University of Florida, and the Department of Biostatistics and Informatics at the University of Colorado Anschutz Medical Campus. Dr. Webb-Robertson’s research focuses on the development of machine learning (ML) and statistical methods in two primary areas; improving downstream analytics from mass spectrometry derived proteomic, metabolomic and lipidomic data and machine learning driven feature extraction focused on biomarker discovery from complex heterogenous data. Her current research is largely focused on understanding the progression of type 1 diabetes. In that context she is currently leading the development of Artificial Intelligence (AI)/ML-ready data for studies of diabetes mellitus funded through the Human Islet Research Network from the National Institutes of Health, the Data Science lead for the national Pancreatic Organ Donors with diabetes (nPOD) program, and a co-I of the Diabetes Autoimmunity Study in the Young (DAISY). Dr. Webb-Robertson received a BA in mathematics from Eastern Oregon University and a ME in Statistics & Operations Research and PhD in Decision Sciences and Engineering Systems from Rensselaer Polytechnic Institute.

Jesse Meyer

Jesse G. Meyer is an Assistant Professor at Cedars Sinai Medical Center in Los Angeles, California. He received his Bachelor of Science degree in Biochemistry in his home state at the University of Minnesota. He then moved to the University of California San Diego to get his PhD in the Chemistry Department. He was a postdoctoral fellow at the Buck Institute for Research on Aging and then the University of Wisconsin Madison. He was named among the Rising Stars in Proteomics and Metabolomics by the Journal of Proteome Research in 2021 and received the ASMS Research Award in 2023. His group does research on human disease by developing and applying techniques at the interface of omics and data science.

Judit Villen

Coming Soon!

Toshiko Tanaka

Coming Soon!

Lisa Jones

Coming Soon!

John Price

John Price grew up farming and ranching in rural Idaho. He was always inspired by how the world restarted every spring by producing new life. He studied Chemistry and Biochemistry at Utah State University in order to understand the mechanisms that produced these amazing results. Starting as an undergraduate he worked with Dr. Lisa Berreau to create synthetic models of enzyme active sites using novel small molecule chelators of metal atoms. His graduate work at Pennsylvania State University used entire enzymes. Here he studied the steps of oxygen activation on iron atoms in dioxygenase enzymes with Drs. J. Martin Bollinger and Carsten Krebs. His success there led to an ambitious project applying kinetic approaches to the study of prion protein aggregates in the brain with Stanley Prusiner at the University of California San Francisco. At UCSF, he published the first proteome scale measurement of in vivo protein turnover. This showed that regulation of protein turnover occurred at the level of the tissue, multiprotein complex, and individual sequence. He was recruited away from UCSF to develop some intellectual property and start a research and development division at a small biotech company. After finishing the commercial development, he decided to continue research into the regulation of protein homeostasis as a faculty member in the Chemistry and Biochemistry Department at Brigham Young University.

Nikolai Slavov

Nikolai Slavov received undergraduate education from MIT and a doctoral degree from Princeton University for characterizing the coordination of cellular growth with gene expression and metabolism. The Slavov laboratory pioneered experimental and computational methods for single-cell proteomics and used them to connect protein covariation across single cells to functional phenotypes, including macrophage polarization, emergence of drug resistance priming, early mammalian development, and stem cell differentiation. These technologies provided a foundation for establishing Parallel Squared Technology Institute (PTI). Prof. Slavov organizes the annual single-cell proteomics conference and contributes to organizing other leading conferences, including NeurIPS.

Sarah Parker

Coming Soon!

Luca Fornelli

Dr. Luca Fornelli earned both his B.Sc. and M.Sc. in Biotechnology from the University of Padova, Italy. He received his PhD under the supervision of Dr. Yury Tsybin at the École Polytechnique Fédérale de Lausanne, Switzerland, with a thesis focused on the characterization of antibodies by middle-down and top-down mass spectrometry. He later obtained a postdoctoral fellowship from the Swiss National Science Foundation and joined the research group of Dr. Neil Kelleher at Northwestern University. Since 2019 Dr. Fornelli works as an Assistant Professor at the University of Oklahoma, where he develops new methods for top-down proteomics. He has been nominated “Emerging Investigator” by the Journal of the American Society for Mass Spectrometry in 2021, and received the ASMS Research Award in the same year. He is also the recipient of the 2022 BBA Rising Star Award.

Ryan Julian

Ryan Julian is a professor of Chemistry at the University of California, Riverside, where he leads a mass spectrometry research group. Dr. Julian obtained his PhD in 2003 at Caltech under the guidance of Jack Beauchamp, focusing on a variety of molecular recognition and ion chemistry projects. He pursued postdoctoral training for two years focused on instrumentation and ion mobility with David Clemmer and Martin Jarrold at Indiana University. Since 2005 in his own lab at UCR, research interests have spanned a broad range of subjects including gas-phase ion chemistry, radical-directed dissociation, antioxidant capacity, and the development of a variety of MS-based structural tools. Most recently, a particular interest in the study of isomerization in long-lived proteins and how these modifications relate to age-related diseases has become a major focus.

Mark Flory

Mark Flory is a Senior Research Scientist at Oregon Health and Science University (OHSU) in Portland and is specifically positioned in the Cancer Early Detection Advanced Research Center (CEDAR) of OHSU’s Knight Cancer Institute. Mark received his Ph.D. in Molecular and Cellular Biology at the University of Washington working in Trisha Davis’ group, and subsequently trained on proteomic mass spectrometry in Ruedi Aebersold’s group at the Seattle Institute for Systems Biology. Mark has since enjoyed professional positions spanning the academic and biotech sectors including work with Parag Mallick in the Canary Center at Stanford for Early Cancer Detection. At OHSU Mark now focuses on implementing powerful proteomic technologies, including Seer Proteograph and Bruker timsTOF mass spectrometry, to facilitate biomarker discovery aimed at uncovering clinically actionable signatures for early cancer detection and to gain new insights into mechanisms underlying disease progression.

Keriann Backus

Keriann Backus is an Assistant Professor of Biological Chemistry and Chemistry and Biochemistry at the University of California, Los Angeles. Her research interests include the developing of new chemical probes, chemoproteomic and proteogenomic methods to study and rewire protein function in health and disease. Dr. Backus received a BS in Chemistry and BA in Latin American Studies in 2007 from Brown University. Her doctoral research was conducted in the laboratories of Benjamin Davis (Oxford) and Clifton Barry (NIH, NIAID) as a 2007 Rhodes Scholar and an NIH Oxford Cambridge Scholar. Her PhD work focused on the development of chemical probes to label and image Mycobacterium tuberculosis. In 2012, Backus completed her doctorate and began an NIH postdoctoral fellowship at The Scripps Research Institute in the laboratory of Benjamin Cravatt. Her postdoctoral research developed chemoproteomic methods for the proteome-wide identification of ligandable cysteine and lysine residues. At UCLA, Dr. Backus's research has been recognized by numerous awards, including a Beckman Young Investigator, DARPA Young Faculty Award, a V Scholar Research Award, Packard Fellowship, NIH New Innovator Award, and Ono Breakthrough Science Initiative Award.

Christopher Parker

Coming Soon!

Summer Gibbs

Dr. Summer Gibbs has 20 years of experience in the field of molecular imaging with expertise in fluorescent contrast agent development and its clinical translation as well as single cell fluorescence imaging technologies. She completed her Ph.D. in Biomedical Engineering under the direction of Brian Pogue, Ph.D. at the Thayer School of Engineering at Dartmouth College in 2008. She joined Dr. John Frangioni’s Laboratory for her postdoctoral training where she completed three years of postdoctoral training and was promoted to Instructor in Medicine. She joined the faculty in the Biomedical Engineering Department at Oregon Health and Science University (OHSU) as an Assistant Professor in June 2012 and was promoted to Professor in July 2022. The current focus of her laboratory is on the development of novel fluorescent probes and fluorescence imaging technologies to improved macroscopic and microscopic patient-specific imaging.

Kristin Burnum-Johnson

Dr. Kristin Burnum-Johnson is a Senior Scientist and Team Lead of the Environmental Molecular Sciences Laboratory’s Metabolomics group at Pacific Northwest National Laboratory (PNNL). Kristin earned her Ph.D. in Biochemistry from Vanderbilt University with Prof. Richard M. Caprioli, and then completed a postdoctoral fellowship at PNNL with Dr. Richard D. Smith. She was selected to receive a 2019 Early Career Research Program award from the U.S. Department of Energy Office of Science. Her research program is dedicated to characterizing the molecular landscape of heterogeneous samples using novel mass spectrometry approaches to address specific biological, medical, and environmental research questions.

Tianhao Yu

Coming Soon!

Nick Riley

Nicholas M. Riley is an Assistant Professor of Chemistry at the University of Washington. He completed his ACS Certified B.S. degree in Chemistry from the University of South Carolina in 2012 with Honors from the South Carolina Honors College, and he earned his Ph.D. in chemistry in 2018 while working on electron-transfer dissociation-centric methodology in the research group of Prof. Joshua J. Coon at the University of Wisconsin-Madison. He then was an NIH K00 and K99 postdoctoral fellow with 2022 Nobel Laureate in Chemistry Prof. Carolyn R. Bertozzi at Stanford University, where he focused on MS-based glycoproteomics and chemical glycobiology. His research program at UW is focused on innovative bioanalytical and chemical biology technologies to investigate essential principles of glycocode regulation and dysregulation.

Ileana Cristea

Coming Soon!

Edward Marcotte

Edward Marcotte obtained his bachelor’s degree and Ph.D. from the University of Texas at Austin and performed a postdoc at UCLA. He is an evolutionary biochemist whose research broadly uses tools of proteomics, bioinformatics, and systems and synthetic biology, with current work focused on the interactions, dynamics, and evolution of proteins across the tree of life. Marcotte has authored 240 journal publications and 23 issued/in process patents, received a National Institutes of Health Director’s Pioneer Award, was elected a Fellow of the Royal Society of Chemistry, the American Academy of Microbiology, and the American Association for the Advancement of Science, and co-founded the single molecule protein sequencing company Erisyon, Inc. He is a Professor in the Department of Molecular Biosciences at the University of Texas, where he holds the Mr. and Mrs. Corbin J. Robertson, Sr. Regents Chair in Molecular Biology.

Lindsay Pino

Lindsay is the co-founder and chief technology officer at Talus Bio. With over a decade’s experience in analytical chemistry and computational biology, she develops technologies for quantitative proteomics. In particular, at Talus, she's working on the challenges associated with scaling-up quantitative proteomics experiments. She is directly involved in a large variety of research projects spanning cancer drug discovery, chemoproteomics, epigenetics, and spatiotemporal proteomics.

Thomas Vondriska

Thomas Vondriska, PhD is a Professor in the Departments of Anesthesiology, Physiology and Medicine (Cardiology) in the David Geffen School of Medicine at UCLA. He is also Vice Chair for Research in the Department of Anesthesiology and Director of the Division of Molecular Medicine. Prior to UCLA, he trained at the University of Louisville in myocardial ischemia, molecular signaling, and proteomics. Dr. Vondriska is an editorial board member at Circulation, American Journal of Physiology and Journal of Molecular & Cellular Cardiology and his lab has been consistently funded by the NIH since its inception. He also co-directs the UCLA Physiology Outreach Program (www.uclapop.org). The Vondriska lab investigates epigenomic processes in the cardiovascular system. Ongoing research examines the molecular basis for remodeling of chromatin architecture in animal models and humans towards the goals of: (1) building basic structure-function models of chromatin in multicellular organisms; (2) understanding epigenomic processes that drive cardiovascular disease; and (3) developing novel therapeutic agents for heart failure that work by remodeling chromatin. The Vondriska lab has trained >50 students, fellows and clinician-scientists (www.vondriskalab.org; Twitter: @VondriskaLab).